Carisma to receive US $ 45 million up-front cash payment and investment by Moderna in the form of a US $ 35 million convertible note
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
It plans to deliver over 300 million doses to the Indian government
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Equity raise to finance growth and investments in the biological space
The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
The value of the contract is estimated to be between Rs 20-30 crores per year for the next three years
CDSCO to fast-track trials and approval for COVID19 vaccine
Subscribe To Our Newsletter & Stay Updated
